findmyKOL
Clinical trialNCT01626352CompletedPhase 2Interventional

Study of Bendamustine and Ofatumumab in Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy

SponsorSCRI Development Innovations, LLCEnrollment22Diffuse Large B-Cell Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Florida Cancer Specialists-South

    Fort Myers, Florida, United States

  • Woodlands Medical Specialists

    Pensacola, Florida, United States

  • Florida Cancer Specialists North

    St. Petersburg, Florida, United States

  • Space Coast Cancer Center

    Titusville, Florida, United States

  • Providence Medical Group

    Terre Haute, Indiana, United States

  • Rhhp/hope Cancer Center

    Terre Haute, Indiana, United States

  • Grand Rapids Oncology Program

    Grand Rapids, Michigan, United States

  • Cancer Centers of Southwest Oklahoma

    Lawton, Oklahoma, United States

  • Oklahoma University

    Oklahoma City, Oklahoma, United States

  • Tennessee Oncology-Chattanooga

    Chattanooga, Tennessee, United States

  • Tennessee Oncology, Pllc

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2012
Primary completion
30 Sept 2016
Completion
30 Apr 2017
Last update posted
22 Nov 2017
Registered enrollment
22
Registry id
NCT01626352

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.